This informal CPD article ‘Understanding ADHD: Evidence-Based Diagnosis, Neurobiology and Effective Intervention’, was provided by Rachel Webb of Phoenix-Kaw Care Consultancy, a health and social care training and consultancy organisation dedicated to improving standards of care across the sector.
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity and impulsivity that interfere with functioning or development (1). Diagnostic criteria require symptoms to be present for at least six months, be developmentally inappropriate, and occur across multiple settings such as home, school or work (1). ADHD affects approximately 5% of children worldwide and around 2.5% of adults, with many individuals experiencing symptoms across the lifespan (2,3).
Neurobiological research
Neurobiological research supports ADHD as a brain-based condition rather than a behavioural choice. Neuroimaging studies demonstrate delayed cortical maturation, particularly in regions associated with executive functioning and attention regulation (4). Executive functioning theory has proposed that ADHD primarily reflects deficits in behavioural inhibition, impacting working memory, emotional regulation and self-monitoring (5). These findings are consistent with evidence implicating dysregulation of dopamine and norepinephrine pathways in attention and impulse control (6).
Presentation can vary across age and gender. Girls are more likely to present with predominantly inattentive symptoms, contributing to under-identification and delayed support (7). In adulthood, hyperactivity may manifest as internal restlessness rather than overt physical movement (3). Recognition of these variations is critical for accurate assessment and intervention.
A multi-modal approach to treatment
The National Institute for Health and Care Excellence (NICE) recommends a comprehensive, multi-modal approach to treatment (8). Medication remains one of the most evidence-supported interventions. A large network meta-analysis found stimulant medications, including methylphenidate and amphetamines, to demonstrate the greatest short-term efficacy in reducing core symptoms in both children and adults (9). These medications increase dopamine and norepinephrine availability, supporting executive functioning and sustained attention (6).
However, medication alone is rarely sufficient. Behavioural interventions are strongly supported within research literature. Parent training programmes, classroom behaviour management and structured reinforcement systems significantly improve functional outcomes (10). A review further supported the role of psychological therapies, including Cognitive Behavioural Therapy (CBT), in improving emotional regulation and coping strategies (11). Organisational skills training and structured environmental supports have also been shown to enhance academic performance and task completion (12).
Educational and workplace adjustments are central to effective ADHD management. Structured routines, clear expectations, visual prompts and task segmentation reduce cognitive overload (12). Movement breaks and environmental modifications support regulation and sustained engagement. In occupational contexts, task prioritisation tools and minimising distractions can significantly improve productivity and wellbeing.
Importantly, a strength-based perspective recognises that individuals with ADHD often demonstrate creativity, innovative thinking, high energy and resilience. When appropriately supported, these strengths can translate into academic, professional and entrepreneurial success.
Final thoughts
Effective ADHD support therefore requires informed assessment, evidence-based intervention and collaborative working between families, educators and healthcare professionals. Integrating neurobiological understanding with practical strategies ensures that individuals with ADHD are not only managed but empowered to thrive.
We hope this article was helpful. For more information from Phoenix-Kaw Care Consultancy, please visit their CPD Member Directory page. Alternatively, you can go to CPD Industry Hubs for more articles, courses and events relevant to your Continuing Professional Development requirements.
REFERENCES
(1) American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
(2) Faraone, S. V., et al. (2015) The worldwide prevalence of ADHD: A meta-analysis. Psychological Medicine
(3) Kessler, R. C., et al. (2006) The prevalence and correlates of adult ADHD. American Journal of Psychiatry
(4) Shaw, P., et al. (2007) Attention-deficit/hyperactivity disorder is characterised by a delay in cortical maturation. Proceedings of the National Academy of Sciences
(5) Barkley, R. A. (1997) Behavioural inhibition, sustained attention and executive functions. Psychological Bulletin
(6) Biederman, J., & Faraone, S. V. (2005) Attention-deficit hyperactivity disorder. The Lancet
(7) Quinn, P. O., & Madhoo, M. (2014) A review of attention-deficit/hyperactivity disorder in women and girls. Current Psychiatry Reports
(8) National Institute for Health and Care Excellence (2018, updated 2019) ADHD: Diagnosis and Management (NG87)
(9) Cortese, S., et al. (2018) Comparative efficacy and tolerability of medications for ADHD. The Lancet Psychiatry
(10) Fabiano, G. A., et al. (2009) A meta-analysis of behavioural treatments for ADHD. Clinical Psychology Review
(11) Daley, D., et al. (2018) Psychological therapies for ADHD in children and adolescents. Cochrane Database of Systematic Reviews
(12) Langberg, J. M., et al. (2011) Organisational skills interventions for children with ADHD. School Psychology Review
